Bristol-Myers Squibb Company (BRM.DE) Stock Price
€41.13 0%
to add to portfolio
AI Score
-
Alternative
6 -
Fundamental
4 -
Technical
5
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Bristol-Myers Squibb Company, AI stock picks, stock alerts and much more.
BRM.DE AI Stock Analysis
AI stock analysis for BRM.DE is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Bristol-Myers Squibb Company (BRM.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Bristol-Myers Squibb Company (BRM.DE) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Bristol-Myers Squibb Company (BRM.DE), currently trading at €41.13, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About BRM.DE
-
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide.
-
Symbol
BRM.DE
-
Market
XETRA
-
Industry
Drug Manufacturers - General
-
Market Cap
83.7B
Similar Stocks
 |
Pfizer Inc. PFE.F |
€21.97 1% |
5 |
 |
Amgen Inc. AMG.DE |
€251.6 2.3% |
6 |
 |
AstraZeneca PLC ZEG.DE |
€138.4 0.7% |
7 |
 |
Pfizer Inc. PFE.DE |
€22.11 0.7% |
5 |
 |
Biogen Inc. IDP.DE |
€119.8 0.3% |
7 |
News
BRM.DE Alternative Data
Web Traffic
Bristol-Myers Squibb Company receives an estimated 1M monthly visitors to bms.com.
-
Web Traffic
1049647
-
Change from Previous Month
32.9%
-
3 Month Change
30.2%
-
YoY Change
30.2%
Twitter Followers
Bristol-Myers Squibb Company has 152,875 Twitter Followers on its main Twitter (also known as X) account, which is down by -0% over the last month.
-
Twitter Followers
152875
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Facebook Engagement
Bristol-Myers Squibb Company has engaged 1,659 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
1659
-
Daily Change
0%
-
1 Month Change
47%
-
3 Month Change
67.9%
-
YoY Change
67.9%
Instagram Followers
Bristol-Myers Squibb Company has 21,710 Instagram Followers on its main Instagram account.
-
Instagram Followers
21710
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
Youtube Subscribers
Bristol-Myers Squibb Company has 5,310 subscribers on its main Youtube channel, up by 18.3% over the last month.
-
Youtube Subscribers
5310
-
Daily Change
0.8%
-
1 Month Change
18.3%
-
3 Month Change
37.6%
Job Postings
Bristol-Myers Squibb Company has an estimated 780 open job postings, which is down -5.2% over the last month.
-
Job Postings
780
-
Daily Change
1.3%
-
1 Month Change
5.2%
-
3 Month Change
16.2%
-
YoY Change
16.2%
Reddit Mentions
Bristol-Myers Squibb Company has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Followers
1,674,955 are following Bristol-Myers Squibb Company on LinkedIn, up by 1.8% over the last month.
-
LinkedIn Followers
1674955
-
Daily Change
1.8%
-
1 Month Change
1.8%
-
3 Month Change
4.6%
-
YoY Change
4.6%
LinkedIn Employees
According to LinkedIn, Bristol-Myers Squibb Company has 38,399 employees, down by -0.2% over the last month.
-
LinkedIn Employees
38399
-
Daily Change
0.2%
-
1 Month Change
0.2%
-
3 Month Change
0.4%
-
YoY Change
0.4%
Business Outlook
According to employee reviews, the business outlook among employees at Bristol-Myers Squibb Company is 42 out of 100 (neutral).
-
Business Outlook
42
-
Change from Previous Month
2.3%
-
3 Month Change
2.3%
-
YoY Change
2.3%
News Mentions
Bristol-Myers Squibb Company was mentioned 11 times in the news yesterday.
-
News Mentions
11
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
-
YoY Change
0%
BRM.DE Financials
BRM.DE Key Metrics
-
Total Revenue
$11.2B
-
Net Income
$2.5B
-
Earnings per Share
$1.21
-
Free cash flow
$1.7B
-
EBITDA
$4.5B
-
EBITDA Ratio
0.399696
-
Total Assets
$92.4B
BRM.DE 2-year Revenue & Income
BRM.DE 2-year Free Cash Flow
BRM.DE Technicals
BRM.DE SMA
BRM.DE RSI
FAQ
What's the current price of Bristol-Myers Squibb Company (BRM.DE) Stock?
The price of an Bristol-Myers Squibb Company (BRM.DE) share is €41.13.
What's the market cap of Bristol-Myers Squibb Company?
The current market cap of Bristol-Myers Squibb Company is 83.7B.
Should I buy or sell BRM.DE?
Bristol-Myers Squibb Company shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Bristol-Myers Squibb Company is better viewed as a hold or accumulate position while waiting for further developments.
Is Bristol-Myers Squibb Company a good investment?
The current analysis of Bristol-Myers Squibb Company's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Bristol-Myers Squibb Company's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Bristol-Myers Squibb Company (BRM.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Bristol-Myers Squibb Company stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Bristol-Myers Squibb Company (BRM.DE) that investors often compare it to?
Bristol-Myers Squibb Company (BRM.DE) is often compared to similar stocks such as Pfizer Inc., Amgen Inc., AstraZeneca PLC, Pfizer Inc. and Biogen Inc..
What is the forecast for Bristol-Myers Squibb Company's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Bristol-Myers Squibb Company's stock price to be around €41.72 in 2026. Starting from the current price of €41.13, this represents a 1.4% change in price, indicating a neutral outlook for the stock.
How to buy Bristol-Myers Squibb Company (BRM.DE) Stock?
Bristol-Myers Squibb Company stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Bristol-Myers Squibb Company shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.